Gregory O. Anglum's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 4,400 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 4,400 | 56,307 (0%) | 0% | - | Class A Common Stock | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 4,400 | 0 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Sale of securities on an exchange or to another person at price $ 11.99 per share. | 11 Feb 2022 | 1,294 | 55,013 (0%) | 0% | 12.0 | 15,518 | Class A Common Stock |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 65,581 | 71,581 (0%) | 0% | - | Class A Common Stock | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 65,581 | 0 | - | - | Phantom Profit Units | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 10 Feb 2022 | 19,674 | 51,907 (0%) | 0% | 12.9 | 253,401 | Class A Common Stock |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 96,876 | 96,876 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,100 | 9,100 | - | - | Stock Options | |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP & General Counsel | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 11 Feb 2021 | 6,000 | 6,000 (0%) | 0% | 13 | 78,000 | Common Stock |
Bioventus Inc - Ordinary S... | Gregory O. Anglum | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 4,400 | 4,400 | - | - | Restricted Stock Units |